Return to program book search
Dermatologic Manifestations of New Oncology Drugs
Sunday, March 03
Palm Ballroom 4
1:00 PM - 3:00 PM
Mario E. Lacouture, MD, FAAD
- Milan J. Anadkat, MD, FAAD
- Jennifer N. Choi, MD, FAAD
- Beth McLellan, MD, FAAD
- Patricia L. Myskowski, MD, FAAD
Following this course, the attendee should be able to:
- Summarize skin, hair, and nail reactions to new chemotherapies in cancer.
- Analyze mechanisms underlying dermatologic reactions to new chemotherapies in cancer.
- Treat dermatologic reactions to new chemotherapies in cancer.
The increased approval of anticancer agents has led to improved quality of life and longer survival times, resulting in millions of individuals living with cancer. Whereas novel drugs are responsible for these achievements, an unexpected constellation of side effects has emerged. Most notably, cutaneous toxicities are notable due to their high frequency, relative effectiveness of anti-skin toxicity interventions, and the otherwise decreasing incidence of systemic or hematopoietic adverse events. This session provides a basis for the understanding and management of dermatologic side effects in the oncology setting, in order to promote attentive care to cutaneous health in cancer patients.
|Sunday, March 03|
|1:00 PM||Introduction to New Oncology Drugs / Dr. Lacouture|
|1:05 PM||Dermatologic Adverse Events to New Cytotoxic Chemotherapies / Dr. Anadkat|
|1:25 PM||Dermatologic Adverse Events to Targeted Therapies / Dr. Lacouture|
|1:50 PM||Getting a Grip on Hand Foot Syndrome / Dr. McLellan|
|2:10 PM||Adverse Events to Topical Anticancer Therapies / Dr. Myskowski|
|2:30 PM||Radiation Therapy Induced Toxicities / Dr. Choi|
|2:50 PM||Panel Discussion / All faculty|